Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
2011

Icaritin Induces Apoptosis in Human Endometrial Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Tong Jing-Shan, Zhang Qing-Hua, Huang Xin, Fu Xue-Qi, Qi Shu-Tao, Wang Ya-Peng, Hou Yi, Sheng Jun, Sun Qing-Yuan

Primary Institution: State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China

Hypothesis

Icaritin has anti-tumor activity and can induce apoptosis in human endometrial cancer cells.

Conclusion

Icaritin inhibits the growth of endometrial cancer Hec1A cells and induces apoptosis through sustained ERK1/2 activation.

Supporting Evidence

  • Icaritin treatment resulted in a dose-dependent reduction of Hec1A cell growth.
  • Icaritin induced apoptosis as evidenced by increased TUNEL-positive cells and caspase activation.
  • Icaritin treatment led to sustained activation of the ERK1/2 signaling pathway.

Takeaway

Icaritin is a compound that can help kill cancer cells in the uterus by making them stop growing and die.

Methodology

The study involved treating Hec1A cells with various concentrations of icaritin and measuring cell growth and apoptosis through assays.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016781

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication